甲状旁腺激素 - Suppr

Suppr

超能文献

Parathyroid hormone.

作者信息

Madore Gigi R, Sherman Pamela J, Lane Joseph M

机构信息

Weill Medical College of Cornell University, New York, NY, USA.

出版信息

J Am Acad Orthop Surg. 2004 Mar-Apr;12(2):67-71. doi: 10.5435/00124635-200403000-00001.

DOI:10.5435/00124635-200403000-00001

PMID:15089079

Abstract

摘要

相似文献

Parathyroid hormone.

J Am Acad Orthop Surg. 2004 Mar-Apr;12(2):67-71. doi: 10.5435/00124635-200403000-00001.

Use of highly potent bisphosphonates in the treatment of osteoporosis.

Curr Osteoporos Rep. 2003 Dec;1(3):116-22. doi: 10.1007/s11914-996-0006-5.

Oral antiresorptive therapy.

Curr Osteoporos Rep. 2004 Dec;2(4):116-22. doi: 10.1007/BF02686924.

Coming to grips with bone loss.

Science. 2004 Sep 3;305(5689):1420-2. doi: 10.1126/science.305.5689.1420.

[Osteoporosis].

Internist (Berl). 2002 Dec;43(12):1529-30, 1533-43. doi: 10.1007/s00108-002-0758-7.

Therapeutic potential of parathyroid hormone.

Curr Osteoporos Rep. 2004 Mar;2(1):5-11. doi: 10.1007/s11914-004-0008-0.

[Correlation between studies and general practice].

MMW Fortschr Med. 2006 Nov 16;148(46):49.

[Risk of osteoporosis in postmenopausal women. When is bone density measurement indicated?].

MMW Fortschr Med. 2004 May 20;146(21):63.

Sequential parathyroid hormone/alendronate therapy for osteoporosis--robbing Peter to pay Paul?

J Clin Endocrinol Metab. 2000 Jun;85(6):2127-8. doi: 10.1210/jcem.85.6.6658.

Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate.

J Clin Endocrinol Metab. 2008 Oct;93(10):3785-93. doi: 10.1210/jc.2008-0353. Epub 2008 Aug 5.

引用本文的文献

The Efficacy and Safety of Chinese Herbal Medicine Xianling Gubao Capsule Combined With Alendronate in the Treatment of Primary Osteoporosis: A Systematic Review and Meta-Analysis of 20 Randomized Controlled Trials.

Front Pharmacol. 2021 Jul 16;12:695832. doi: 10.3389/fphar.2021.695832. eCollection 2021.

Effects of alendronate for treatment of glucocorticoid-induced osteoporosis: A meta-analysis of randomized controlled trials.

Medicine (Baltimore). 2018 Oct;97(42):e12691. doi: 10.1097/MD.0000000000012691.

Synergistic effects of high dietary calcium and exogenous parathyroid hormone in promoting osteoblastic bone formation in mice.

Br J Nutr. 2015 Mar 28;113(6):909-22. doi: 10.1017/S0007114514004309. Epub 2015 Mar 6.

Atrophic femoral nonunion successfully treated with teriparatide.

Eur J Orthop Surg Traumatol. 2013 Nov;23 Suppl 2:S291-4. doi: 10.1007/s00590-012-1143-4. Epub 2012 Dec 9.

Recent advances toward the clinical application of PTH (1-34) in fracture healing.

HSS J. 2009 Sep;5(2):149-53. doi: 10.1007/s11420-009-9109-8. Epub 2009 Mar 17.

Alendronate inhibits PTH (1-34)-induced bone morphogenetic protein expression in MC3T3-E1 preosteoblastic cells.

HSS J. 2007 Sep;3(2):169-72. doi: 10.1007/s11420-007-9042-7. Epub 2007 Mar 31.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Parathyroid hormone.

J Am Acad Orthop Surg. 2004 Mar-Apr;12(2):67-71. doi: 10.5435/00124635-200403000-00001.

Use of highly potent bisphosphonates in the treatment of osteoporosis.

Curr Osteoporos Rep. 2003 Dec;1(3):116-22. doi: 10.1007/s11914-996-0006-5.

Oral antiresorptive therapy.

Curr Osteoporos Rep. 2004 Dec;2(4):116-22. doi: 10.1007/BF02686924.

Coming to grips with bone loss.

Science. 2004 Sep 3;305(5689):1420-2. doi: 10.1126/science.305.5689.1420.

[Osteoporosis].

Internist (Berl). 2002 Dec;43(12):1529-30, 1533-43. doi: 10.1007/s00108-002-0758-7.

Therapeutic potential of parathyroid hormone.

Curr Osteoporos Rep. 2004 Mar;2(1):5-11. doi: 10.1007/s11914-004-0008-0.

[Correlation between studies and general practice].

MMW Fortschr Med. 2006 Nov 16;148(46):49.

[Risk of osteoporosis in postmenopausal women. When is bone density measurement indicated?].

MMW Fortschr Med. 2004 May 20;146(21):63.

Sequential parathyroid hormone/alendronate therapy for osteoporosis--robbing Peter to pay Paul?

J Clin Endocrinol Metab. 2000 Jun;85(6):2127-8. doi: 10.1210/jcem.85.6.6658.

Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate.

J Clin Endocrinol Metab. 2008 Oct;93(10):3785-93. doi: 10.1210/jc.2008-0353. Epub 2008 Aug 5.

引用本文的文献

Front Pharmacol. 2021 Jul 16;12:695832. doi: 10.3389/fphar.2021.695832. eCollection 2021.

Effects of alendronate for treatment of glucocorticoid-induced osteoporosis: A meta-analysis of randomized controlled trials.

Medicine (Baltimore). 2018 Oct;97(42):e12691. doi: 10.1097/MD.0000000000012691.

Synergistic effects of high dietary calcium and exogenous parathyroid hormone in promoting osteoblastic bone formation in mice.

Br J Nutr. 2015 Mar 28;113(6):909-22. doi: 10.1017/S0007114514004309. Epub 2015 Mar 6.

Atrophic femoral nonunion successfully treated with teriparatide.

Eur J Orthop Surg Traumatol. 2013 Nov;23 Suppl 2:S291-4. doi: 10.1007/s00590-012-1143-4. Epub 2012 Dec 9.

Recent advances toward the clinical application of PTH (1-34) in fracture healing.

HSS J. 2009 Sep;5(2):149-53. doi: 10.1007/s11420-009-9109-8. Epub 2009 Mar 17.

Alendronate inhibits PTH (1-34)-induced bone morphogenetic protein expression in MC3T3-E1 preosteoblastic cells.

HSS J. 2007 Sep;3(2):169-72. doi: 10.1007/s11420-007-9042-7. Epub 2007 Mar 31.